Dutch Biotech fighting ALS and other neuro-degenerative diseases gets European backing

Imported from official source

Announcement

The European Investment Bank (EIB) has signed a €30 million convertible loan agreement with Amsterdam-based VectorY Therapeutics, a clinical-stage biotechnology company developing a novel treatment for neurodegenerative diseases. The financing, supported by the European Commission’s InvestEU programme, will help accelerate the development of VectorY’s vectorised antibody platform, which can help to better treat neuro-degenerative diseases, and expand its pipeline. The EIB financing is part of a broader financing syndicate comprised of new investors and existing shareholders.

Source: European Investment Bank.

Read the original at the source: https://www.eib.org/en/press/all/2026-413-dutch-biotech-fighting-als-and-other-neuro-degenerative-diseases-gets-european-backing

Officially imported this from European Investment Bank’s own source. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.

Provenance

Organization
European Investment Bank — imported from official source
Official source
https://www.eib.org/en/press/all/index.rss RSS
Imported
November 11, 2026 13:01
Versions
1 recorded
Identity
https://www.eib.org/en/press/all/2026-413-dutch-biotech-fighting-als-and-other-neuro-de...

Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.